Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
30 milliliters of 0.9% NaCl
- Development stage
- Preclinical
- Lead developer
- Centrum Medyczne Kształcenia Podyplomowego
- Modality
- Small Molecules
- Administration
- Parenteral
01
Overview
30 milliliters of 0.9% NaCl is a sterile, physiologically inert normal saline solution used as a placebo comparator in clinical trials. In the context of trial NCT03600129, sponsored by the Centre of Postgraduate Medical Education, it is administered via bilateral, ultrasound-guided Quadratus Lumborum Block (QLB) to patients undergoing endoscopic (laparoscopic) prostatectomy. It serves as the inactive control arm to evaluate the efficacy of ropivacaine for postoperative pain management. Because it is a simple saline solution, it possesses no intrinsic pharmacological activity or specific biological targets.
- Other names
- 0.9% NaCl0.9% sodium chloridenormal salinesaline solution
Beyond the preview
Go deeper on 30 milliliters of 0.9% NaCl.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 30 milliliters of 0.9% NaCl.